Evaluation of Xerostomia Following 3 Dimensional Conformal Radiotherapy for Nasopharyngeal Cancer Patients
![]() |
Park Young-Je
(Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Park Won (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Ju Sang-Gyu (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Nam Hee-Rim (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Oh Dong-Ryul (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Park Hee-Chul (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Ahn Yong-Chan (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | Yeh CK, Johnson DA, Dodds MW. Impact of aging on human salivary gland function: a community based study. Aging 1998; 10:421-428 |
2 | Lim JH, Kim GW, Keum KC, et al. Parotid sparing radiotherapy technique using 3-D conformal radiotherapy for nasopharyngeal carcinoma. J Korean Soc Ther Radiol Oncol 2000; 18:1-10 |
3 | Malouf JG, Aragon C, Henson BS, et al. Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients. Cancer Detection and Prevention 2003;27: 305-310 DOI ScienceOn |
4 | Ng MK, Porceddu SV, Milner AD, et al. Parotid-sparing Radiotherapy: does it really reduce xerostomia? Clin Oncol 2005;17:610-617 DOI ScienceOn |
5 | Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-1317 DOI |
6 | Franzen L, Funegard U, Ericson T, et al. Parotid gland function during and following radiotherapy of malignancies in the head and neck: a consecutive study of salivary flow and patient discomfort. Eur J Cancer 1992;28:457-462 DOI ScienceOn |
7 | Kosuda S, Satoh M, Yamamoto F, et al. Assessment of salivary gland dysfunction following chemoradiotherapy using quantitative salivary gland scintigraphy. Int J Radiat Oncol Biol Phys 1999;45:379-384 DOI ScienceOn |
8 | Eisbruch A, Kim HM, Ten Haken R, et al. Dose, volume and function relationships in parotid glands following conformal and intensity modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1996;45:577-587 |
9 | Wu Q, Manning M, Schmidt-Ullirich R, et al. The potential for sparing of parotids and escalation of biologically equivalent dose with intensity modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000;46:195-205 DOI ScienceOn |
10 | Longma LP, Highman SM, Bucknall R, et al. Signs and symptoms in patients with salivary gland hypofunction. Postgrad Med J 1997;73:93-97 DOI |
11 | Yeh SA, Tang Y, Lui CC, et al. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 2005;62:672-679 DOI ScienceOn |
12 | Chao KSC, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;51:938-946 DOI ScienceOn |
13 | Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al. Development of European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients: EORTC Quality of Life Study Group. Acta Oncol 1994;33:897- 885 |
14 | Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 1994;28:847-856 DOI ScienceOn |
15 | Chan AT, Teo PM, Ngan RK, et al. Concurrent chemotherapy- radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progressionfree survival analysis of a phase III randomized trial. J Clin Oncol 2002;20:2038-2044 DOI ScienceOn |
16 | Lee SH, Kim TH, Chie EK, et al. Evaluation of xerostomia following intensity modulated radiotherapy (IMRT) for head and neck cancer patients. J Korean Soc Ther Radiol Oncol 2004; 22:106-114 과학기술학회마을 |
17 | Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head-andneck cancer. Int J Radiat Oncol Biol Phys 2001;50:695-703 DOI ScienceOn |
18 | Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579 DOI |
19 | Kwong DL, Sham JS, Au GK, et al. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol 2004;22:2643-2653 DOI ScienceOn |
20 | Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with AJCC/UICC (1997) stage 3 and 4 nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005;23:6730-6738 DOI ScienceOn |
21 | Amosson CM, Teh BS, Van TJ, et al. Dosimetric predictors of xerostomia for head and neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. Int J Radiat Oncol Biol Phys 2003;56:136- 144 DOI ScienceOn |
22 | Jen YM, Shin R, Lin YS, et al. Parotid gland-sparing 3- dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy. Radiother Oncol 2005;75:204-209 DOI ScienceOn |
23 | Braam PM, Roesink JM, Moerland MA, et al. Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys 2005;50:695-703 |
24 | Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma. Cancer 2004;101:1584-1593 DOI ScienceOn |
25 | Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003;21:631-637 DOI ScienceOn |
26 | Marks JE, Davis CC, Gottsman VL, et al. The effects of radiation on parotid salivary function. Int J Radiat Oncol Biol Phys 1981;7:1013-1019 DOI ScienceOn |
27 | Vissink A, Panders AK, Gravenmade EJ, et al. The causes and consequences of hyposalivation. Ear Nose Throat 1988;67:166-176 |
![]() |